Infusion site erythema: treatments, associated drugs and conditions
Summary:
Infusion site erythema: reddening of the skin at infusion site.
We study 8,203 people who have Infusion site erythema. The information that eHealthMe analyzes includes:
- Medications that treat Infusion site erythema and their effectiveness- 649 drugs that are associated with Infusion site erythema
Number of reports submitted per year:

All the drugs that are associated with Infusion site erythema:
- Infusion site erythema (649 drugs)
Do you take any medication?
- You can use our AI-powered tools to monitor drug safety and effectiveness.Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
How we gather our data?
Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference. Browse all conditions on eHealthMe.
Recent studies on eHealthMe:
- Drug interactions of Clopidogrel and Magnesia - 14 seconds ago
- Drug interactions of Baclofen and Meclizine Hydrochloride - 16 seconds ago
- Could Omeprazole cause Osteoarthritis? - 18 seconds ago
- Could Acetaminophen cause Heart Valve Surgery? - 23 seconds ago
- Could Celebrex cause Yellow Skin? - 24 seconds ago
- Drug interactions of Senna and Atropine - 28 seconds ago
- Drug interactions of Vascepa and Meclizine - 29 seconds ago
- Could Folic Acid cause Paroxysmal Nocturnal Haemoglobinuria? - 33 seconds ago
- Drug interactions of Vitamin D and Naloxone Hydrochloride - 34 seconds ago
- Drug interactions of Singulair and Patanase - 44 seconds ago